Journal Article

Induction of different types of uterine adenocarcinomas in Donryu rats due to neonatal exposure to high-dose <i>p-t-</i>octylphenol for different periods

Midori Yoshida, Shin-ichi Katsuda, Tomo Tanimoto, Sayaka Asai, Dai Nakae, Yuji Kurokawa, Kazuyoshi Taya and Akihiko Maekawa

in Carcinogenesis

Volume 23, issue 10, pages 1745-1750
Published in print October 2002 | ISSN: 0143-3334
Published online October 2002 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/23.10.1745
Induction of different types of uterine adenocarcinomas in Donryu rats due to neonatal exposure to high-dose p-t-octylphenol for different periods

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Inappropriate exposure to estrogens in the fetal and/or newborn period can exert irreversible influence, including carcinogenesis on the reproductive system in mammals. The present study was conducted to investigate uterine carcinogenesis in Donryu rats treated neonatally with a high-dose estrogenic compound, p-t-octylphenol (OP) for different exposure periods. Female Donryu rats were subcutaneously administered 100 mg/kg/day OP every other day for the first 5 postnatal days (PNDs 1–5) or the first 2 weeks (PNDs 1-15). They received a single injection of 20 mg/kg N-ethyl-N′-nitro-N-nitrosoguanidine (ENNG) into a uterine horn at 11 weeks of age and were examined until 15 months of age. PNDs 1–5 OP-treated rats showed normal development of the female reproductive system, including uterine gland genesis and normal estrous cycling after vaginal opening. The treatment, however, accelerated an earlier occurrence of persistent estrus and increased the number of well differentiated uterine adenocarcinomas as compared with controls. This indicated that PNDs 1–5 OP treatment acts as a delayed modulator of the hypothalamus-pituitary-ovarian hormonal control system and the modulation increased the serum estrogen:progesterone ratio, resulting in induction of uterine tumors. On the contrary, PNDs 1–15 OP treatment demonstrated immediate and irreversible influences on the control system, called ‘androgenization‘, and induced abnormal uterine development manifested by prolonged persistent estrus immediately after vaginal opening and also suppression of uterine gland genesis. In addition, uterine tumor malignancy in morphological and biological property clearly increased in this group although the total number of adenocarcinomas was not increased. The present study provides evidence that neonatal exposure to a high-dose OP enhances uterine carcinogenesis in rats, and the type of uterine tumors is changed by the periods of neonatal exposure to OP, suggesting that the mechanism of uterine tumor development is dependent upon neonatal exposure periods.

Keywords: DES, diethylstilbestrol; ENNG, N-ethyl-N′-nitro-N-nitrosoguanidine; ERα, estrogen receptor α; FSH, follicle-stimulating hormone; LH, luteinizing hormone; OP, p-t octylphenol; PNDs, postnatal days.

Journal Article.  4674 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.